91 related articles for article (PubMed ID: 20375664)
1. Perspective on the optimal endpoints for pulmonary arterial hypertension trials.
Rubin L; Simonneau G
Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S43-6. PubMed ID: 20375664
[TBL] [Abstract][Full Text] [Related]
2. Clinical worsening in trials of pulmonary arterial hypertension: results and implications.
Galiè N; Simonneau G; Barst RJ; Badesch D; Rubin L
Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S11-9. PubMed ID: 20375660
[TBL] [Abstract][Full Text] [Related]
3. Endpoints in pulmonary arterial hypertension: the role of clinical worsening.
Peacock A; Keogh A; Humbert M
Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S1-9. PubMed ID: 20375659
[TBL] [Abstract][Full Text] [Related]
4. Assessment of endpoints in the pediatric population: congenital heart disease and idiopathic pulmonary arterial hypertension.
Haworth SG; Beghetti M
Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S35-41. PubMed ID: 20375663
[TBL] [Abstract][Full Text] [Related]
5. Assessment of endpoints in pulmonary arterial hypertension associated with connective tissue disease.
Coghlan JG; Pope J; Denton CP
Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S27-34. PubMed ID: 20375662
[TBL] [Abstract][Full Text] [Related]
6. Assessing effectiveness of pulmonary arterial hypertension therapies in daily practice.
Sitbon O; Hoeper MM; Simonneau G
Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S21-6. PubMed ID: 20375661
[TBL] [Abstract][Full Text] [Related]
7. Clinical trial designs in PAH: shifting from functional measurements to long-term clinical outcomes.
Studer SM; Gilkin RJ
Am J Manag Care; 2014 Mar; 20(6 Suppl):S115-22. PubMed ID: 24716456
[TBL] [Abstract][Full Text] [Related]
8. Medical treatment of pulmonary arterial hypertension.
Adamali H; Gaine SP; Rubin LJ
Semin Respir Crit Care Med; 2009 Aug; 30(4):484-92. PubMed ID: 19634087
[TBL] [Abstract][Full Text] [Related]
9. Exercise as an end-point in pulmonary hypertension trials.
McCullagh B; Girgis RE
Int J Clin Pract Suppl; 2010 Jan; (165):4-6. PubMed ID: 19958394
[TBL] [Abstract][Full Text] [Related]
10. "Just Another Statistic".
Machtay M; Glatstein E
Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
[TBL] [Abstract][Full Text] [Related]
11. Current treatment strategies for pulmonary arterial hypertension.
Lee SH; Rubin LJ
J Intern Med; 2005 Sep; 258(3):199-215. PubMed ID: 16115293
[TBL] [Abstract][Full Text] [Related]
12. Outcome measures in pulmonary arterial hypertension associated with systemic sclerosis.
Kowal-Bielecka O; Delcroix M; Vonk-Noordegraaf A; Hoeper MM; Naeije R
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v39-41. PubMed ID: 18784140
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary arterial hypertension and rheumatic diseases--from diagnosis to treatment.
Distler O; Pignone A
Rheumatology (Oxford); 2006 Oct; 45 Suppl 4():iv22-5. PubMed ID: 16980719
[TBL] [Abstract][Full Text] [Related]
14. Prostanoid therapy for pulmonary arterial hypertension.
Badesch DB; McLaughlin VV; Delcroix M; Vizza CD; Olschewski H; Sitbon O; Barst RJ
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):56S-61S. PubMed ID: 15194179
[TBL] [Abstract][Full Text] [Related]
15. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.
Singh TP; Rohit M; Grover A; Malhotra S; Vijayvergiya R
Am Heart J; 2006 Apr; 151(4):851.e1-5. PubMed ID: 16569546
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension.
Galiè N; Seeger W; Naeije R; Simonneau G; Rubin LJ
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):81S-88S. PubMed ID: 15194183
[TBL] [Abstract][Full Text] [Related]
17. Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertension.
Gomberg-Maitland M; Huo D; Benza RL; McLaughlin VV; Tapson VF; Barst RJ
J Heart Lung Transplant; 2007 Jul; 26(7):732-8. PubMed ID: 17613405
[TBL] [Abstract][Full Text] [Related]
18. Endpoints for assessing drug activity in clinical trials.
Pazdur R
Oncologist; 2008; 13 Suppl 2():19-21. PubMed ID: 18434634
[TBL] [Abstract][Full Text] [Related]
19. Continuous hemodynamic monitoring in patients with pulmonary arterial hypertension.
Frantz RP; Benza RL; Kjellström B; Bourge RC; Barst RJ; Bennett TD; McGoon MD
J Heart Lung Transplant; 2008 Jul; 27(7):780-8. PubMed ID: 18582809
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
